Abstract
Olfactory dysfunction has been reported in Parkinson’s disease (PD) patients carrying the LRRK2 G2019S variant in Caucasians but rarely in those with the LRRK2 G2385R variant. In this study, we performed genotyping for the LRRK2 G2385R variant in PD patients recruited from the Movement Disorder Clinic of Xuanwu Hospital in Beijing and in healthy controls randomly selected from the Beijing Longitudinal Study on Aging cohort. The “five-odor olfactory detection array”, an olfactory threshold test, was used to assess olfactory function. One hundred and eighty-six participants were enrolled, comprising 43 PD patients without (iPD) and 25 with (LRRK2-PD) the LRRK2 G2385R variant, and 118 healthy controls. Our results showed that the threshold of olfactory identification was significantly worse in PD patients than in controls, but not significantly different between the iPD and LRRK2-PD groups. These findings suggested that although olfactory function in LRRK2-PD patients is impaired, it is similar to that in iPD patients.
References
Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988, 38: 1237–1244.
Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, et al. Prevalence of smell loss in Parkinson’s disease–a multicenter study. Parkinsonism Relat Disord 2009, 15: 490–494.
Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1997, 62: 436–446.
Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al. Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 2008, 63: 167–173.
Healy DG, Falchi M, O’Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study. Lancet Neurol 2008, 7: 583–590.
Khan NL, Jain S, Lynch JM, Pavese N, Abou-Sleiman P, Holton JL, et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson’s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005, 128: 2786–2796.
Ruiz-Martinez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodriguez F, et al. Olfactory deficits and cardiac 123I-MIBG in Parkinson’s disease related to the LRRK2 R1441G and G2019S mutations. Mov Disord 2011, 26: 2026–2031.
Saunders-Pullman R, Stanley K, Wang C, San Luciano M, Shanker V, Hunt A, et al. Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 2011, 77: 319–324.
Wang C, Cai Y, Gu Z, Ma J, Zheng Z, Tang BS, et al. Clinical profiles of Parkinson’s disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals. Neurobiol Aging 2014, 35: 725 e721–726.
Li DW, Gu Z, Wang C, Ma J, Tang BS, Chen SD, et al. Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants. J Neural Transm (Vienna) 2015, 122: 661–667.
Tian X, Tang Z, Jiang J, Fang X, Wu X, Han W, et al. Effects of smoking and smoking cessation on life expectancy in an elderly population in Beijing, China, 1992-2000: an 8-year follow-up study. J Epidemiol 2011, 21: 376–384.
Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988, 51: 745–752.
Wu X, Yu C, Fan F, Zhang K, Zhu C, Wu T, et al. Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson’s disease. Eur Neurol 2011, 66: 98–105.
Sun AN CX, Hai XL. Development of ‘five odors olfactory detection arrays’ and olfactory threshold testing in health young people. Chin J Otorhinolaryngol 1992, 27: 35–38.
Su M, Wang S, Fang W, Zhu Y, Li R, Sheng K, et al. Alterations in the limbic/paralimbic cortices of Parkinson’s disease patients with hyposmia under resting-state functional MRI by regional homogeneity and functional connectivity analysis. Parkinsonism Relat Disord 2015, 21: 698–703.
Zhang LiYan CP. Olfactory function in patients with Parkinson’s disease. Chin J Neurol 2004, 37: 529–532.
Farrer MJ, Stone JT, Lin CH, Dachsel JC, Hulihan MM, Haugarvoll K, et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson’s disease in Asia. Parkinsonism Relat Disord 2007, 13: 89–92.
Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004, 19: 1020–1028.
Doty RL. Influence of age and age-related diseases on olfactory function. Ann N Y Acad Sci 1989, 561: 76–86.
Vilas D, Ispierto L, Alvarez R, Pont-Sunyer C, Marti MJ, Valldeoriola F, et al. Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers. Parkinsonism Relat Disord 2015, 21: 1170–1176.
Mirelman A, Heman T, Yasinovsky K, Thaler A, Gurevich T, Marder K, et al. Fall risk and gait in Parkinson’s disease: the role of the LRRK2 G2019S mutation. Mov Disord 2013, 28: 1683–1690.
Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease. J Neurol 2007, 254: 84–90.
Hawkes CH, Shephard BC. Selective anosmia in Parkinson’s disease? Lancet 1993, 341: 435–436.
Daum RF, Sekinger B, Kobal G, Lang CJ. Olfactory testing with “sniffin’ sticks” for clinical diagnosis of Parkinson disease. Nervenarzt 2000, 71: 643–650.
Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 2003, 60: 545–549.
Fu X, Zheng Y, Hong H, He Y, Zhou S, Guo C, et al. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson’s disease in a Han Chinese population from Southern Mainland China. Parkinsonism Relat Disord 2013, 19: 397–398.
Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 1995, 10: 283–287.
Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson’s disease by olfactory bulb pathology. Lancet 1992, 340: 186.
Hawkes CH, Shephard BC, Daniel SE. Is Parkinson’s disease a primary olfactory disorder? QJM 1999, 92: 473–480.
Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 2015, 72: 100–105.
Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, et al. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 2008, 71: 1021–1026.
Acknowledgements
This work was supported by grants from the Scientific Project of Ministry of Science and Technology of China (2012AA02A514), the National Basic Research Development Program of China (2011CB504101), and the Beijing High Standard Health Human Resource Cultural Program in Health System, China (2009e1e12).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cao, M., Gu, ZQ., Li, Y. et al. Olfactory Dysfunction in Parkinson’s Disease Patients with the LRRK2 G2385R Variant. Neurosci. Bull. 32, 572–576 (2016). https://doi.org/10.1007/s12264-016-0070-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12264-016-0070-5